Zoom Profit Outlook Misses Estimates – AI Costs Hit Hard
Zoom’s FY2027 earnings guidance fell below Wall Street forecasts due to rising AI expenses. Q4 revenue beat but profit missed.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Zoom’s FY2027 earnings guidance fell below Wall Street forecasts due to rising AI expenses. Q4 revenue beat but profit missed.
H.C. Wainwright upgrades JOBY to Buy with $18 target on final-stage FAA progress and eIPP catalyst. Joby beats Q4 loss ($0.14 vs $0.20 expected) and cash ($1.41B vs $1.01B), eyes first passengers in Dubai via Uber + US early ops this year.
Celsius (CELH) smashed Q4 2025 expectations — revenue doubled to $721.6M, adjusted EPS jumped 86%, and Alani Nu is flying in PepsiCo’s system.
Baidu’s (BIDU) latest results show slowing revenue and tough AI competition, yet cloud growth, overseas robotaxis, and a new $5B buyback + dividend signal brighter days ahead.
C3.ai just reported weak Q3 2026 results, missed expectations, slashed its revenue outlook, and announced major layoffs under its new CEO. Stock plunged ~23% premarket.
AMD is partnering with Nutanix, investing $150 million in equity and $100 million in cash to develop easy-to-use AI platforms. Nutanix also beat Q2 earnings expectations, reporting 10% revenue growth.